Nirvana Life Sciences Inc. announced that Health Canada has given Nirvana an approval to build out its Research & Development facility in Vancouver, Canada. Health Canada's Office For Controlled Substances & Authorizations Division has reviewed Nirvana's proposed floor plan and design and has concluded that the GMP level 9 secure facility to be built in Vancouver satisfies the directive for physical security requirements if built as proposed. Health Canada has given the company notice that construction can be initiated at the Vancouver location.

Once construction has been completed, the company will inform Health Canada and schedule an inspection to confirm the completed build complies with the directive in order to be an approved Licensed Dealer. Nirvana has contracted Stratus Designs Ltd. to design and implement the control systems required to meet the stringent security requirements of Health Canada. The Stratus team has the experience and skill set to see the build out of the facility to completion in a way that will optimize efficiency and to meet GACP and GMP standards.

Once completed, the Licensed Dealer License will give Nirvana the ability to import, export, analyze, research, and develop along with the sale of controlled substances to qualified investigators and to other Licensed Dealers. Nirvana has also already purchased $800,000 worth of state-of-the-art laboratory equipment to be deployed into the facility upon final inspection and approval from Health Canada.